Anti-mouse CD8α-InVivo

Catalog No.A2102        Batch: A210219

       Clone No.2.43

Print

Anti-mouse CD8α (Clone:2.43)reacts with mouse CD8α. CD8 is a transmembrane glycoprotein that acts as a co-receptor for the T cell receptor (TCR). It binds to class I MHC molecules displayed by antigen presenting cells (APC).

Technical Data

Formulation PBS buffer, pH 7.0
Clone 2.43
Immunogen Mouse CTL clone L3
Isotype Rat IgG2b, κ
Application In vivo CD8+ T cell depletion,WB
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Sterility 6.94 mg/mL
Purity 99%
Protein concentration 6.94 mg/mL
Endotoxin Level <1 EU/mg

Customer Product Validation

Selleck's Anti-mouse CD8α-InVivo has been cited by 20 publications

cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation [ Sci Immunol, 2024, 9(98):eadk2612] PubMed: 39093956
Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity [ Cell Rep Med, 2024, 5(5):101533] PubMed: 38744278
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade [ J Immunother Cancer, 2024, 12(9)e009327] PubMed: 39244215
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer [ Cancer Lett, 2024, 589:216836.] PubMed: 38556105
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment [ Cell Rep, 2024, 43(9):114697] PubMed: 39217611
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function [ Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00959-1] PubMed: 38809326
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709.] PubMed: 38001101
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709] PubMed: 38001101
Enhanced Chemo-Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer [ Adv Sci (Weinh), 2023, 10(35):e2303819] PubMed: 37875399
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4(10):101229] PubMed: 37820722

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.